+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07163403

Pilot Study to Evaluate Safety and Immune Response of Personalized Dendritic Cell Therapy for Preventing Cancer in Adults with Lynch Syndrome

Led by Fundacion Clinic per a la Recerca Biomédica · Updated on 2026-04-13

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and immune response of a new treatment using a patients own dendritic cells loaded with frameshift-derived neopeptides to prevent cancer in people with Lynch Syndrome. This pilot, open-label study is the first time this treatment is tested in humans and is not randomized. It is sponsored by Fundacion Clinic per a la Recerca Biomdica and focuses on individuals who carry genetic variants linked to Lynch Syndrome but have no active or previous invasive cancer. Eligible participants will receive six doses of their own specially prepared dendritic cells called DC-DELAY through intradermal immunizations at weeks 0, 2, 4, 6, 8, and 10. This treatment aims to stimulate the immune system to recognize cancer-related proteins. The study will monitor participants for up to three years to track immune responses and any signs of cancer development. Participants will be closely monitored through blood tests, colonoscopies, and biopsies to assess safety and immune response at various time points including weeks 6 and 12, and months 6, 12, 24, and 36. Researchers will look for side effects, immune reactions, and the presence of precancerous or cancerous lesions. Participants must continue regular standard care surveillance with colonoscopies every 1 to 2 years. The total study duration involves follow-ups for up to three years after the last immunization.

CONDITIONS

Brief Title

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Research Team

L

Laura Burunat, Graduate

T

Thomas Walle, Doctor of Medicine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here